Pulmonx Ownership | Who Owns Pulmonx?


OverviewForecastRevenueFinancialsChartTranscripts

Pulmonx Ownership Summary


Pulmonx is owned by 7.59% institutional investors, 10.76% insiders, and 81.66% retail investors. Primecap management co/ca/ is the largest institutional shareholder, holding 11.55% of LUNG shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 8.73% of its assets in Pulmonx shares.

LUNG Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPulmonx7.59%10.76%81.66%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryMedical Device Stocks37.54%10.61%51.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Primecap management co/ca/4.73M11.55%$10.45M
Morgan stanley4.16M10.16%$9.19M
Blackrock2.67M6.90%$16.91M
Blackrock funding, inc. /de2.71M6.61%$5.98M
Vanguard group2.54M6.21%$5.61M
Fmr2.17M5.41%$3.52M
Soleus capital management2.04M4.98%$4.50M
Silvercrest asset management group1.26M3.15%$2.05M
Deutsche bank ag\1.13M2.75%$2.49M
Kent lake pr926.16K2.30%$1.50M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kent lake capital328.29K0.94%$2.08M
Stonepine capital management670.00K0.88%$1.09M
Kent lake pr926.16K0.76%$1.50M
Soleus capital management2.04M0.17%$4.50M
Nano cap new millennium growth fund l p85.00K0.16%$187.85M
Perkins capital management49.00K0.09%$108.29K
Parkman healthcare partners500.66K0.08%$811.07K
Cfm wealth partners264.04K0.08%$583.53K
Gsa capital partners llp403.76K0.08%$892.00K
Vestal point capital, lp830.00K0.06%$1.34M

Top Buyers

HolderShares% AssetsChange
Soleus capital management2.04M0.17%2.04M
Kent lake pr926.16K0.76%926.16K
Vestal point capital, lp830.00K0.06%830.00K
Morgan stanley4.16M0.00%539.79K
Stonepine capital management670.00K0.88%524.10K

Top Sellers

HolderShares% AssetsChange
Fmr2.17M0.00%-2.09M
Deerfield management company, l.p. (series c)---1.89M
Bnp paribas asset management---1.17M
Victory capital management---834.30K
Altium capital management lp---815.00K

New Positions

HolderShares% AssetsChangeValue
Soleus capital management2.04M0.17%2.04M$4.50M
Kent lake pr926.16K0.76%926.16K$1.50M
Vestal point capital, lp830.00K0.06%830.00K$1.34M
Kent lake capital328.29K0.94%328.29K$2.08M
Westfield capital management co lp184.90K0.00%184.90K$408.64K

Sold Out

HolderChange
Clearstead advisors-1.00
Nelson, van denburg & campbell wealth management group-7.00
Bryn mawr trust-8.00
True wealth design-9.00
Quadrant capital group-11.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202520-81.31%3,105,451-90.25%70.12%9-83.33%6-80.00%
Sep 30, 202528-75.22%4,194,703-88.43%100.13%12-79.66%7-79.41%
Jun 30, 2025113-5.83%36,256,1460.28%901.10%583.57%346.25%
Mar 31, 20259-92.62%3,281,067-90.85%80.10%4-93.44%--100.00%
Dec 31, 20241225.17%35,871,0671.30%911.12%61-7.58%3214.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
PRIMECAP Odyssey Aggressive Growth3.60M8.73%-32.40K
Fidelity Small Cap Growth1.49M3.67%-
Vanguard US Total Market Shares ETF1.16M2.92%-
Vanguard Total Stock Mkt Idx Inv1.15M2.79%-
Fidelity Select Pharmaceuticals Port958.75K2.35%-
iShares Russell 2000 ETF890.38K2.16%158.73K
Xtrackers S&P 500 Swap ETF 1C692.75K1.68%-5.11K
Strategic Advisers Fidelity US TtlStk660.30K1.64%-
Vanguard US Opportunities Ins USD Acc666.79K1.62%-
Fidelity Advisor Small Cap I628.39K1.54%-190.41K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 02, 2026Radhakrishnan Srikanth Chief Science &Techn. OfficerSell$6.00K
Mar 02, 2026Radhakrishnan Srikanth Chief Science &Techn. OfficerSell$1.08K
Mar 02, 2026Radhakrishnan Srikanth Chief Science &Techn. OfficerSell$3.52K
Mar 02, 2026Radhakrishnan Srikanth Chief Science &Techn. OfficerSell$4.39K
Mar 02, 2026French Glendon E. III President and CEOSell$3.87K

Insider Transactions Trends


DateBuySell
2026 Q1-15
2025 Q4-11
2025 Q3-12
2025 Q2115
2025 Q1-16

LUNG Ownership FAQ


Who Owns Pulmonx?

Pulmonx shareholders are primarily institutional investors at 7.59%, followed by 10.76% insiders and 81.65% retail investors. The average institutional ownership in Pulmonx's industry, Medical Device Stocks, is 37.54%, which Pulmonx falls below.

Who owns the most shares of Pulmonx?

Pulmonx’s largest shareholders are Primecap management co/ca/ (4.73M shares, 11.55%), Morgan stanley (4.16M shares, 10.16%), and Blackrock (2.67M shares, 6.90%). Together, they hold 28.62% of Pulmonx’s total shares outstanding.

Does Blackrock own Pulmonx?

Yes, BlackRock owns 6.90% of Pulmonx, totaling 2.67M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.91M$. In the last quarter, BlackRock decreased its holdings by -370K shares, a -12.17% change.

Who is Pulmonx’s biggest shareholder by percentage of total assets invested?

Kent lake capital is Pulmonx’s biggest shareholder by percentage of total assets invested, with 0.94% of its assets in 328.29K Pulmonx shares, valued at 2.08M$.

Who is the top mutual fund holder of Pulmonx shares?

PRIMECAP Odyssey Aggressive Growth is the top mutual fund holder of Pulmonx shares, with 8.73% of its total shares outstanding invested in 3.6M Pulmonx shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools